These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17487699)

  • 1. Effect of farmorubicin both free and associated with poly(butylcyanoacrylate) nanoparticles on phagocytic and NK activity of peritoneal exudate cells from tumor-bearing mice.
    Simeonova MY; Antcheva MN
    J Drug Target; 2007 May; 15(4):302-10. PubMed ID: 17487699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on the effect of polybutyl-2-cyanoacrylate nanoparticles and their metabolites on the phagocytic activity of peritoneal exudate cells of mice.
    Simeonova M; Antcheva M; Chorbadjiev K
    Biomaterials; 2003 Jan; 24(2):313-20. PubMed ID: 12419633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological hallmarks of cis-DDP-resistant Lewis lung carcinoma cells.
    Fedorchuk O; Susak Y; Rudyk M; Senchylo N; Khranovska N; Skachkova O; Skivka L
    Cancer Chemother Pharmacol; 2018 Feb; 81(2):373-385. PubMed ID: 29290023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deoxycholic acid modified-carboxymethyl curdlan conjugate as a novel carrier of epirubicin: in vitro and in vivo studies.
    Gao F; Li L; Zhang H; Yang W; Chen H; Zhou J; Zhou Z; Wang Y; Cai Y; Li X; Liu L; Zhang Q
    Int J Pharm; 2010 Jun; 392(1-2):254-60. PubMed ID: 20347028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(butylcyanoacrylate) nanoparticles.
    Cabeza L; Ortiz R; Arias JL; Prados J; Ruiz Martínez MA; Entrena JM; Luque R; Melguizo C
    Int J Nanomedicine; 2015; 10():1291-306. PubMed ID: 25709449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epirubicin loading in poly(butyl cyanoacrylate) nanoparticles manifests via altered intracellular localization and cellular response in cervical carcinoma (HeLa) cells.
    Evangelatov A; Skrobanska R; Mladenov N; Petkova M; Yordanov G; Pankov R
    Drug Deliv; 2016 Sep; 23(7):2235-2244. PubMed ID: 25268149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical characterization and in vitro behavior of daunorubicin-loaded poly(butylcyanoacrylate) nanoparticles.
    Simeonova M; Ivanova G; Enchev V; Markova N; Kamburov M; Petkov C; Devery A; O'Connor R; Brougham D
    Acta Biomater; 2009 Jul; 5(6):2109-21. PubMed ID: 19250892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diminished genotoxicity of mitomycin C and farmorubicin included in polybutylcyanoacrylate nanoparticles.
    Blagoeva PM; Balansky RM; Mircheva TJ; Simeonova MI
    Mutat Res; 1992 Jul; 268(1):77-82. PubMed ID: 1378189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK depletion results in increased CCL22 secretion and Treg levels in Lewis lung carcinoma via the accumulation of CCL22-secreting CD11b+CD11c+ cells.
    Mailloux AW; Clark AM; Young MR
    Int J Cancer; 2010 Dec; 127(11):2598-611. PubMed ID: 20198623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro induction of natural killer cells by cloned human tumor necrosis factor.
    Voth R; Rossol S; Gallati H; Pracht I; Laubenstein HP; Hess G; Müller WE; Schröder HC; Jochum C; Meyer zum Büschenfelde KH
    Cancer Immunol Immunother; 1988; 27(2):128-32. PubMed ID: 2458181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the therapeutic efficacy of VEGFR-1-targeted polymer drug conjugates in mouse tumor models.
    Shamay Y; Golan M; Tyomkin D; David A
    J Control Release; 2016 May; 229():192-199. PubMed ID: 27001892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on the possible causes of decreasing NK cell activity in tumor-bearing mice. II. Serum and peritoneal exudate from ascitic tumor-bearing mice suppress NK cell activity].
    Fu JY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Dec; 11(6):446-8. PubMed ID: 2534583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epirubicin loaded to pre-polymerized poly(butyl cyanoacrylate) nanoparticles: preparation and in vitro evaluation in human lung adenocarcinoma cells.
    Yordanov G; Evangelatov A; Skrobanska R
    Colloids Surf B Biointerfaces; 2013 Jul; 107():115-23. PubMed ID: 23466549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer Effect of Cisplatin-Loaded Poly (Butylcyanoacrylate) Nanoparticles on A172 Brain Cancer Cells Line.
    Chiani M; Toofani Milani A; Nemati M; Rezaeidian J; Ehsanbakhsh H; Ahmadi Z; Mazloomi E; Sadeghi V; Akbarzadeh Khiyavi A
    Asian Pac J Cancer Prev; 2019 Jan; 20(1):303-309. PubMed ID: 30678454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(butylcyanoacrylate) nanoparticles for topical delivery of 5-fluorouracil.
    Simeonova M; Velichkova R; Ivanova G; Enchev V; Abrahams I
    Int J Pharm; 2003 Sep; 263(1-2):133-40. PubMed ID: 12954188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity and apoptotic gene expression in an in vitro model of the blood-brain barrier following exposure to poly(butylcyanoacrylate) nanoparticles.
    Hall AM; Hemmer R; Spaulding R; Wetzel HN; Curcio J; Sabel BA; Henrich-Noack P; Pixley S; Hopkins T; Boyce RL; Schultheis PJ; Haik KL
    J Drug Target; 2016 Aug; 24(7):635-44. PubMed ID: 26707984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of doxorubicin inclusion into phospholipid nanoparticles on tumor accumulation and specific activity].
    Medvedeva NV; Torkhovskaya TI; Kostryukova LV; Zakharova TS; Kudinov VA; Kasatkina EO; Prozorovskiy VN; Ipatova OM
    Biomed Khim; 2017 Jan; 63(1):56-61. PubMed ID: 28251952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total flavonoids of Daphne genkwa root significantly inhibit the growth and metastasis of Lewis lung carcinoma in C57BL6 mice.
    Zheng W; Gao X; Chen C; Tan R
    Int Immunopharmacol; 2007 Feb; 7(2):117-27. PubMed ID: 17178377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro effect of imatinib mesylate loaded on polybutylcyanoacrylate nanoparticles on leukemia cell line K562.
    Hasandoost L; Akbarzadeh A; Attar H; Heydarinasab A
    Artif Cells Nanomed Biotechnol; 2017 May; 45(3):665-669. PubMed ID: 27133178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disulfide-cross-linked PEG-block-polypeptide nanoparticles with high drug loading content as glutathione-triggered anticancer drug nanocarriers.
    Chen YF; Chang CH; Lin CY; Lin LF; Yeh ML; Jan JS
    Colloids Surf B Biointerfaces; 2018 May; 165():172-181. PubMed ID: 29482128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.